Review article: Nutritional therapy in alcoholic liver disease

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 4, 2003, Pages 357-373

  Stickel, F ^a   Hoehn, B ^b   Schuppan, D ^a   Seitz, H K ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Krankenhaus Salem   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METADOXINE; PHOSPHATIDYLCHOLINE; POLYENE PHOSPHATIDYLCHOLINE; S ADENOSYLMETHIONINE; THIAMINE; TRACE ELEMENT; UNCLASSIFIED DRUG;

ALCOHOL LIVER DISEASE; CARBOHYDRATE DIET; ENTERIC FEEDING; FATTY LIVER; FEMALE; FOLIC ACID DEFICIENCY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER DYSFUNCTION; LIVER TOXICITY; MALE; MALNUTRITION; MORTALITY; NITROGEN BALANCE; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CALORIE MALNUTRITION; PROTEIN DIET; REVIEW; SURVIVAL; THIAMINE DEFICIENCY;

FOOD, FORMULATED; HUMANS; LIVER DISEASES, ALCOHOLIC; NUTRITION DISORDERS; PARENTERAL NUTRITION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0042329273     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01660.x     Document Type: Review

References (104)

1. Kim WR, Brown RS, Terrault NA. et al. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002; 36: 227-42.
2. Corrao G, Ferrari P, Zambon A, et al. Trends of liver cirrhosis mortality in Europe, 1970-89: age-period-cohort analysis and changing alcohol consumption. Int J Epidemiol 1997; 26: 100-9.
3. Grant BF, DeBakey S, Zobeck TS. Surveillance Report no. 18. Liver cirrhosis mortality in the United States 1991, 1973-88. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism. Division of Biometry and Epidemiology, U.S. Department of Health and Human Services.
4. Fisher NC, Hanson J, Phillips A, et al. Mortality from liver disease in the West Midlands. 1993-2000: observational study. Br Med J 2002; 325: 312-3.
5. John U, Hanke M. Alcohol-attributable mortality in a high per capita consumption country - Germany. Alcohol Alcohol 2002; 37: 581-5.
6. Ishak KG, Zimmerman HJ, Ray MB. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res 1991; 15: 45-66.
7. Menon KV, Gores GJ, Shah VH. Pathogenesis, diagnosis, and treatment of alcoholic liver disease. Mayo Clin Proc 2001; 76: 1021-9.
8. Stickel F, Schuppan D, Hahn EG, et al. Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 2002; 51: 132-9.
9. Teli MR, Day CP, Burt AD, et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995; 346: 987-90.
10. McCullough AJ, O'Connor JFB. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 2022-36.
11. Neuberger J, Schulz KH, Day C. et al. Transplantation for alcoholic liver disease. J Hepatol 2002; 36: 130-7.
12. Eriksson CJ. The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol Clin Exp Res 2001; 25(Suppl. 5): 15S-32S.
13. Seitz HK, Suter PM. Ethanol toxicity and nutritional status. In: Kotsonis, FN, Mackey, MA, eds. Nutritional Toxicology, 2nd edn. New York: Taylor & Francis. 2002. 122-54.
14. Langhans W. Role of the liver in the metabolic control of eating: what we know - and what we do not know. Neurosci Biobeh Rev 1996; 20: 145-53.
15. Felver ME, Mezey E. McGuire M, et al. Plasma tumor necrosis factor alpha predicts long-term survival in severe alcoholic hepatitis. Alc Clin Exp Res 1990; 14: 255-9.
16. McCullough AJ, Bugianesi E, Marchesini G. et al. Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 1998; 115: 947-53.
17. Geokas MC, Lieber CS, French S, et al. Ethanol, the liver and the gastrointestinal tract. Ann Int Med 1981; 95: 198-211.
18. Mezey E. Effect of ethanol on intestinal morphology, metabolism, and function. In: Seitz, HK, Kommerell, B, eds. Alcohol Related Diseases in Gastroenterology. New York: Springer, 1985, 342-60.
19. Tremblay A, Buemann N, Theriault G, et al. Body fatness in active individuals reporting low lipid and alcohol intake. Eur J Clin Nutr 1995; 49: 824-31.
20. Suter PM. Alcohol. its role in health and nutrition. In: Bowman, BA, Russell, RM, eds. Present Knowledge in Nutrition, 3rd edn. Washington, D.C.: International Life Science Institute Press, 2001, 497-507.
21. Niebergall-Roth E, Harder H, Singer MV. A review: acute and chronic effects of ethanol and alcoholic beverages on the pancreatic exocrine secretion in vivo and in vitro. Alcohol Clin Exp Res 1998; 22: 1570-83.
22. Kondrup J, Müller MJ. Energy and protein requirements of patients with chronic liver disease. J Hepatol 1997; 27: 239-47.
23. Lieber CS. Alcohol: its metabolism and interaction with nutrients. Ann Rev Nutr 2000; 20: 395-430.
24. Müller MJ, Lautz HU. Plogmann B, et al. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992; 12: 782-94.
25. Selberg O. Burchert W, vd Hoff J, et al. Insulin resistance in liver cirrhosis. Positron tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest 1993; 91: 1897-902.
26. Bianchi G, Marchesini G, Zoli M, et al. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994; 20: 119-25.
27. World MJ, Ryle PR, Pratt D, et al. Alcohol and body weight. Alcohol Alcohol 1984; 19: 1-6.
28. Gloria L, Cravo M, Camilo, ME, et al. Nutritional deficiencies in chronic alcoholics: relation to dietary intake and alcohol consumption. Am J Gastroenterol 1997; 92: 485-9.
29. Hidiroglu N, Camilo ME, Beckenhauer HC, et al. Effect of chronic alcohol ingestion on hepatic folate distribution in the rat. Biochem Pharmacol 1994; 47: 1561-6.
30. Fernandez O. Carreras O, Murillo ML. Intestinal absorbtion and enterohepatic circulation of folic acid: effect of ethanol. Digestion 1998; 59: 130-3.
31. Russell RM, Rosenberg IH, Wilson PD, et al. Increased urinary excretion and prolonged turnover time of folic acid during ethanol ingesiton. Am J Clin Nutr 1983; 38: 64-70.
32. Fonda ML, Brown SG, Pendleton MW. Concentration of vitamin B6 and activity of enzymes of B6 metabolism in the blood of alcoholic and nonalcoholic men. Alc Clin Exp Res 1989; 3: 804-9.
33. Bovet P, Larue D, Fayol V, et al. Blood thiamine status and determinants in the population of Seychelles (Indian Ocean). J Epidemiol Community Health 1998; 52: 148-57.
34. Seitz HK. Alcohol and retinoid metabolism. Gut 2000; 47: 748-05.
35. Leo MA, Lieber CS, Alcohol, vitamin A. and beta-carotene: adverse interactions including hepatotoxicity and carcinogenensis. Am J Clin Nutr 1999; 69: 1071-85.
36. Leo MA, Lieber CS. Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 1982; 307: 597-601.
37. Liu C, Russell RM, Seitz HK, et al. Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology 2001; 120: 179-89.
38. Chung J, Liu C, Smith DE, et al. Restoration of retinoic acid concentration suppresses ethanol-enhanced c-Jun expression and hepatocyte proliferation in rat liver. Carcinogenesis 2001; 22: 1213-9.
39. Pirlich M, Selberg O, Boker K, et al. The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis. Hepatology 1996; 24: 1422-7.
40. Prijatmoko D, Strauss BJG, Lambert JR, et al. Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis. Gastroenterology 1993; 103: 1839-45.
41. Nielsen K, Kondrup J, Martinsen L, et al. Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis. Br J Nutr 1993; 69: 665-79.
42. Simko V, Connell AM, Banks B. Nutritional status in alcoholics with and without liver disease. Am J Clin Nutr 1982; 35: 197-203.
43. Mendenhall CL, Anderson S, Weesner RE, et al. Protein-calory malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Am J Med 1984; 76: 211-22.
44. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. Nutritional status in cirrhosis. J Hepatol 1994; 21: 317-25.
45. Caregaro L, Alberino F, Amodio P, et al. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr 1996; 63: 602-9.
46. Sarin SK, Dhingra N, Bansal A, et al. Dietary and nutritional abnormalities in alcoholic liver disease: a comparison with chronic alcoholics without liver disease. Am J Gastro 1997; 92: 777-83.
47. Mendenhall CL, Roselle GA, Gartide P, et al. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alc Clin Exp Res 1995; 19: 635-41.
48. Müller MJ. Lautz HU, Plogmann B, et al. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992; 15: 782-94.
49. Merli M, Riggio O, Dally L, PINC. Does malnutrition affect survival in cirrhosis? Hepatology 1996; 23: 1041-6.
50. McCormick PA, Morgan MY, Phillips A, et al. The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal hemorrhage. J Hepatol 1992; 14: 99-103.
51. Selberg O, Bottcher J, Tusch G, et al. Identification of high and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997; 25: 652-7.
52. Mathurin P, Duchatelle V, Ramond MJ, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996; 110: 1847-53.
53. Galambos JT, Hersh T, Fulenwider JT, et al. Hyperalimentation in alcoholic hepatitis. Am J Gastroenterol 1979; 72: 535-41.
54. Mendenhall CL, Bongiovanni G, Goldberg S, et al. VA cooperative study on alcoholic hepatitis. III: changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. J Parenter Enteral Nutr 1985; 9: 590-6.
55. Calvey H, Davis M, Williams R. Controlled trial of nutritional supplementation, with and without branched chain amino acids enrichment, in treatment of acute alcoholic hepatitis. J Hepatol 1985; 1: 141-51.
56. Soberon S, Pauley MP, Duplantier R, et al. Metabolic effects of enteral formula feeding in alcoholic hepatitis. Hepatology 1987; 7: 1204-9.
57. Cabre E, Rodriguez-Iglesias P, Caballeria J, et al. Short-term and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000; 32: 36-42.
58. Mendenhall CL, Anderson S, Garcia-Pont P, et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984; 311: 1464-70.
59. Mendenhall CL, Moritz TE, Roselle GA, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993; 17: 564-76.
60. Nasrallah JM, Galambos JT. Amino acid therapy of alcoholic hepatitis. Lancet 1980; II: 1276-7.
61. Diehl AM, Boitnott JK, Herlong HF, et al. Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology 1985; 5: 57-63.
62. Naveau S, Pelletier G, Poynard T, et al. A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients. Hepatology 1986; 6: 270-4.
63. Achord JL. A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis. Am J Gastroenterol 1987; 82: 871-5.
64. Simon J, Galambos JT. A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. J Hepatol 1988; 7: 200-7.
65. Mezey E, Caballeria J, Mitchell MC, et al. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial. Hepatology 1991; 14: 1090-6.
66. Fan ST, Lo CM, Lai ECS, et al. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 1994; 331: 1547-52.
67. Bonkovsky H, Fiellin DA, Smith GS, et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I: short-term effects on liver function. Am J Gastro 1991; 86: 1200-8.
68. Bonkovsky H, Singh RH, Jafri ICH, et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition. Am J Gastroenterol 1991; 86: 1209-18.
69. Smith J, Horowitz J, Henderson JM, et al. Enteral hyperalimentation in undernourished patients with cirrhosis and ascites. Am J Clin Nutr 1982; 2: 1276-7.
70. Keohane PP, Attrill H, Grimble G, et al. Enteral nutrition in malnourished patients with hepatic cirrhosis and acute encephalopathy. J Parenter Enteral Nutr 1983; 7: 346-50.
71. McGhee A, Henderson JM, Millikan WJ, et al. Comparison of the effects of hepatic-aid and casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Ann Surg 1983; 197: 288-93.
72. Christie ML, Sack DM, Pomposelli J, et al. Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis. J Parent Ent Nutr 1985; 9: 671-8.
73. Okita M, Watanabe A, Nagashima H. Nutritional treatment of liver cirrhosis by branched-chain amino acid-enriched nutrient mixture. J Nutr Sci Vitaminol 1985; 31: 291-303.
74. Bunout D, Aicardi V, Hirsch S, et al. Nutritional support in hospitalized patients with alcoholic liver disease. Eur J Clin Nutr 1989; 43: 615-21.
75. Cabre E, Gonzales-Huix F, Abad-Lacruz A, et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990; 98: 715-20.
76. Marchesini G, Dioguardi FS, Bianchi GP, et al. Long term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. J Hepatol 1990; 11: 92-101.
77. Kearns PJ, Young H, Garcia G, et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992; 102: 200-5.
78. Hirsch S, Bunout D, De la Maza MP, et al. Controlled trial on nutritional supplementation in outpatients with symptomatic alcoholic cirrhosis. J Parent Enter Nutr 1993; 17: 119-24.
79. Nielsen K, Kondrup J, Martinsen L, et al. Long-term oral refeeding of patients with cirrhosis of the liver. Br J Nutr 1995; 74: 557-67.
80. Campillo B, Bories PN, Leluan M, et al. Short-term changes in energy metabolism after 1 month of a regular oral diet in severely malnourished cirrhotic patients. Metabolism 1995; 44: 765-70.
81. Hirsch S, de la Maza MP, Gattas V, et al. Nutritional support in alcoholic cirrhotic patients improves host defenses. J Am Coll Nutr 1999; 18: 434-41.
82. Martinez-Chantar ML, Garcia-Trevijano ER, Latasa MU, et al. Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury. Am J Clin Nutr 2002; 76 (Suppl.): 1177S-82S.
83. Avila MA, Garcia-Trevijano ER, Martinez-Chantar ML, et al. S-adenosylmethionine revisited: its essential role in the regulation of liver function. Alcohol 2002; 27: 163-7.
84. Trimble KC, Molloy AM, Scott JM, et al. The effect of ethanol on one-carbon metabolism: increased methionine catabolism and methyl-group wastage. Hepatology 1993; 18: 984-9.
85. Halsted CH, Villanueva J, Chandler CJ, et al. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation. Hepatology 1996; 23: 497-505.
86. Stickel F, Choi SW, Kim YI, et al. Effect of chronic alcohol consumption on total plasma homocysteine levels in rats. Alcohol Clin Exp Res 2000; 24: 259-64.
87. Finkelstein J-D. Methionine metabolism in mammals. J Nutr Biochem 1990; 1: 228-36.
88. Lieber CS, Leo MA, Mak KM, et al. Choline fails to prevent liver fibrosis in ethanol-fed baboons but causes toxicity. Hepatology 1985; 5: 561-72.
89. Lieber CS. S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings. Alcohol 2002; 27: 173-7.
90. Avila MA, Berasain C, Torres L, et al. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol 2000; 33: 907-14.
91. Frezza M, Surrenti C, Manzillo G, et al. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology 1990; 99: 211-5.
92. Vendemiale G, Altomare E, Trizio T, et al. Effect of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastro 1989; 24: 407-15.
93. Loguerico C, Nardi G, Argenzio F, et al. Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease. Alcohol Alcohol 1994; 29: 597-604.
94. Mato JM, Camara J, Fernandez de Paz J, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicentre clinical trial. J Hepatol 1999; 30: 1081-9.
95. Lieber CS, Robins SJ, Leo MA. Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcohol Clin Exp Res 1994; 18: 592-5.
96. Seitz HK, Dornacher I, Sawatzki T, et al. Proton-decoupled 31P MR spectroscopy for the assessment of hepatic phospholipid metabolism in patients with alcoholic liver disease. Hepatology 2002; 36: A411 (Abstract).
97. Lieber CS, Robins SJ, Li J, et al. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994; 106: 152-9.
98. Lieber CS. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol 2000; 32 (Suppl. 2): 113-28.
99. Panos MZ, Polson R, Johnson R, et al. Polyunsaturated phosphatidylcholine for acute alcoholic hepatitis: a double-blind, randomized, placebo-controlled trial. Europ J Gastroenterol Hepatol 1990; 2: 351-5.
100. Schuller-Perez A, Gonzales San Martin F. Placebo-controlled study with polyunsaturated phosphatidylcholine in alcoholic steatosis of the liver. Med Welt 1985; 36: 517-21.
101. Knuchel F. Double-blind study in patients with alcoholic toxic fatty liver. Effect of essential phospholipids on enzyme behaviour and lipid composition of the serum. Med Welt 1979; 30: 411-6.
102. Lieber CS, Weiss DG, Groszmann R, et al. Effect of moderation of ethanol consumption combined with PPC administration on liver injury in alcoholics: prospective, randomized, placebo-controlled, multicenter VA trial (CSP 391). Hepatology 2002; 36: 381A (Abstract).
103. Caballeria J, Pares A, Bru C, et al. Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. J Hepatol 1998; 28: 54-60.
104. Lochs H, Plauth M. Liver cirrhosis, rationale and modalities for nutritional support - the European Society of Parenteral and Enteral Nutrition consensus and beyond. Curr Opin Clin Nutr Metab Care 1999; 2: 345-9.